ETFs Investing in Proto Labs, Inc. Stocks
This article lists various ETFs that invest in Proto Labs, Inc. stocks, providing details such as market value, weight, issuer, management style, expense ratio, and AUM for each fund. It highlights that these ETFs make investing in stocks more accessible and offer opportunities with lower risk. The data presented covers a wide range of ETFs, including those focused on small-cap, value, growth, and thematic investments like robotics and AI.
What Proto Labs (PRLB)'s Russell 2000 Defensive Index Additions Mean For Shareholders
Proto Labs (PRLB) has been added to the Russell 2000 Defensive and Russell 2000 Value-Defensive Indices, potentially increasing its exposure to passive and institutional investors. While this inclusion may boost share demand, the company's core focus remains on scaling its digital manufacturing platform, particularly in CNC and sheet metal growth, and addressing challenges in legacy prototyping and injection molding. The launch of ProDesk, an AI-powered quoting and design tool, is seen as crucial for deepening customer engagement and offsetting weaknesses in older service lines, with future revenue projected to be $659.4 million and earnings $50.5 million by 2029.
Proto Labs, Inc.(NYSE:PRLB) added to Russell 2000 Defensive Index
Proto Labs, Inc. (NYSE: PRLB) has been added to the Russell 2000 Defensive Index. This inclusion highlights the company's position within a significant market index, focusing on defensive stocks among small-cap companies. The announcement was made on June 28, 2026, further emphasizing its market presence.
Price to earnings forward of Proto Labs, Inc. – NYSE:PRLB
This article provides a brief financial overview of Proto Labs, Inc. (NYSE: PRLB), specifically focusing on its forward price-to-earnings ratio. The content indicates that the company's financial data is provided by reputable sources like ICE Data Services and FactSet. It also highlights the integration of SEC filings and documents through Quartr.
Price to book forward of Proto Labs, Inc. – SWB:PRZ
The article reports on the price to book forward metric for Proto Labs, Inc. (SWB:PRZ). It appears to be a financial data point presented within the TradingView platform, indicating market data specifics for the company. The content itself is minimal, primarily focusing on displaying this particular financial ratio.
Proto Labs, Inc.(NYSE: PRLB) added to Russell 2000 Value-Defensive Index
Proto Labs, Inc. (NYSE: PRLB) has been added to the Russell 2000 Value-Defensive Index. This announcement highlights the company's inclusion in a significant market index, indicating its standing within the small-cap value segment. The article also provides recent news about Protolabs, including executive changes and Q1 2026 earnings results.
Price to sales forward of Proto Labs, Inc. – NYSE:PRLB
This article provides a financial data point for Proto Labs, Inc. (NYSE: PRLB), specifically its "Price to sales forward" value. The content is sparse, serving as a placeholder within a larger financial data platform, likely TradingView, and does not elaborate on the meaning or implications of this metric. It primarily presents the company's stock symbol and the exchange it trades on.
Enterprise value to EBITDA forward of Proto Labs, Inc. – SWB:PRZ
The article focuses on the enterprise value to EBITDA forward metric for Proto Labs, Inc. (SWB:PRZ), traded on the Stuttgart Stock Exchange. It appears to be a financial data snippet or a specific page from a financial tracking platform like TradingView, providing an overview of the company's financial data. The content highlights the period, value, and change of this specific financial metric.
Proto Labs, Inc. Actuals & Estimates (NYSE:PRLB)
This article provides an overview of Proto Labs, Inc. (NYSE:PRLB), including its current stock price, historical performance, and analyst forecasts. It also details the company's financial actuals and estimates, such as earnings per share and revenue, and key financial metrics like market capitalization and EBITDA. The report indicates that Proto Labs' stock has seen significant growth over the last year and analysts generally recommend a "buy" rating.
Proto Labs, Inc. Actuals & Estimates (FWB:PRZ)
This article provides an overview of Proto Labs, Inc. (FWB:PRZ) financial actuals and estimates, including income statement, balance sheet, and cash flow data relevant to investors. It details analyst forecasts for PRZ stock, its historical high and low prices, upcoming earnings reports, and other key financial metrics like revenue, net income, EBITDA, and employee count. The article also provides guidance on how to buy Proto Labs, Inc. stock and clarifies that the company does not pay dividends.
Stronger Earnings and Institutional Inflows Might Change The Case For Investing In Proto Labs (PRLB)
Proto Labs (PRLB) has reported strong quarterly revenue growth of 10.40% and significant net profit growth, along with increased institutional ownership. This improved financial performance and institutional confidence are strengthening the company's investment narrative, especially with the launch of its AI-enabled e-commerce platform, ProDesk. While the company still carries a moderate to high-risk profile, analysts are projecting continued growth and a fair value of $75.67.
Is It Time To Consider Buying Proto Labs, Inc. (NYSE:PRLB)?
This article evaluates Proto Labs, Inc. (NYSE:PRLB) as a potential investment by analyzing its fair value based on future cash flows and comparing it to the current share price. It uses a discounted cash flow (DCF) model and considers analyst price targets and valuation metrics. The analysis suggests that Proto Labs might be undervalued.
Is It Time To Consider Buying Proto Labs, Inc. (NYSE:PRLB)?
This article analyzes Proto Labs, Inc. (PRLB) using a discounted cash flow (DCF) model to determine its intrinsic value. The analysis suggests that PRLB might be undervalued by 26% based on future cash flow projections. The piece also acknowledges the limitations and assumptions inherent in DCF modeling while highlighting factors like stock volatility, growth rates, and the company's financial health.
Proto Labs Inc (PRLB) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides an overview of Proto Labs Inc (PRLB) dividends and stock splits. It states that no dividend data is available for the past five years and no stock split information has been recorded. The page also presents current stock performance metrics for PRLB.
Proto Labs Inc (PRLB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
The article provides a detailed revenue breakdown for Proto Labs Inc (PRLB), categorizing its income by business segments and geographical regions. It highlights that CNC Machining and Injection Molding are the largest revenue contributors, with the United States generating the vast majority of the company's revenue. The financial data presented includes revenue proportions for various segments and regions.
Proto Labs stock hits 52-week high at 78.73 USD
Proto Labs Inc. (PRLB) stock recently hit a 52-week high of $78.73, marking a 101% surge over the past year and 54% year-to-date. This strong performance follows robust Q1 2026 financial results, where the company exceeded revenue and EPS expectations. Despite this growth, InvestingPro analysis suggests the stock might be overvalued.
Proto Labs stock hits 52-week high at 78.73 USD By Investing.com
Proto Labs Inc. (PRLB) stock has reached a new 52-week high of $78.73, surging 101% over the past year and 54% year-to-date. Despite this impressive growth, an InvestingPro analysis suggests the stock might be overvalued. The company also reported strong Q1 2026 financial results, exceeding analyst expectations for EPS and revenue, and shareholders approved several key proposals at their annual meeting.
Proto Labs stock hits 52-week high at 78.73 USD By Investing.com
Proto Labs Inc. (PRLB) stock reached a new 52-week high of $78.73, representing a 101% surge over the past year and 54% year-to-date, despite InvestingPro suggesting it may be overvalued. This growth follows strong Q1 2026 financial results where the company exceeded analyst expectations for EPS and revenue, and shareholders approved director nominees and an amendment to the long-term incentive plan.
Assessing Proto Labs (PRLB) Valuation After Strong Q1 Growth And New Commercial Leadership
Proto Labs (PRLB) is gaining attention due to strong Q1 results, double-digit revenue growth, and the appointment of a new Chief Commercial Officer. Its stock has seen significant returns over the past year, approaching its analyst price target. While the most popular narrative suggests it's 1% overvalued at $75.67 due to strong momentum in CNC machining and sheet metal, investors should also consider risks like soft European demand and reliance on large Aerospace & Defense accounts.
Proto Labs stock hits 52-week high at 78.73 USD By Investing.com
Proto Labs Inc. (PRLB) stock recently hit a 52-week high of $78.73, following a 101% surge over the past year and 54% year-to-date. Despite this growth, an InvestingPro analysis suggests the stock might be overvalued. The company also reported strong Q1 2026 financial results, exceeding analyst expectations, and shareholders approved director nominees and an amendment to their incentive plan.
Proto Labs (PRLB) director reports open-market sale of 2,000 shares
Proto Labs Inc. director Sven Wehrwein reported the open-market sale of 2,000 shares of common stock on June 2, 2026, across two transactions at different price points. Despite these sales, Wehrwein retains over 32,000 shares, indicating the transaction was a relatively small portion of his overall holdings. This sale was disclosed via a Form 4 filing with the SEC, detailing the share amounts, prices, and his remaining beneficially owned shares.
Proto Labs Board Member Sold $154K In Company Stock
A Proto Labs board member, SVEN WEHRWEIN, sold 2,000 shares of the company's stock for a total of $154,550 on June 4, according to an SEC filing. The article details Proto Labs' financial health, including revenue growth, gross margin, EPS, and debt management, and discusses the significance of insider transactions for investors. Proto Labs (NYSE: PRLB) is an on-demand manufacturer of custom parts for prototyping and short-run production.
Insider Sell: Sven Wehrwein Sells 2,000 Shares of Proto Labs Inc (PRLB)
Sven Wehrwein, a Director at Proto Labs Inc, sold 2,000 shares of the company on June 2, 2026, reducing his total holdings to 32,505 shares. The stock is currently trading at $77.28, which, against a GF Value of $43.99, indicates that it is significantly overvalued. Proto Labs' price-earnings ratio of 70.57 is also considerably higher than both the industry median and the company's historical median.
Proto Labs, Inc. Hits New 52-Week High of $78.41, Up 145.53%
Proto Labs, Inc. has reached a new 52-week high of $78.41, demonstrating a significant one-year return of 145.53%, far exceeding the S&P 500's performance. The company, a small-cap player in specialty chemicals with a market capitalization of $1,313 million, shows efficient inventory management and positive revenue trends. Despite long-term challenges with declining operating profit, Proto Labs maintains financial stability with a low debt-to-equity ratio.
Proto Labs stock hits 52-week high at $78.44
Proto Labs Inc. (PRLB) stock reached a new 52-week high of $78.44, reflecting a strong performance with a 1-year change of 106.74%. The company boasts a perfect Piotroski Score of 9 and more cash than debt, indicating strong financial health. Despite this, InvestingPro analysis suggests the stock is currently overvalued relative to its Fair Value.
[144] Proto Labs Inc SEC Filing
This article details a Form 144 SEC filing by Proto Labs Inc. (PRLB), indicating a proposed sale of 2000 shares of common stock with an aggregate market value of $151,900.00. The filing, dated June 1, 2026, notes the securities were acquired on May 19, 2026, as a stock award from the issuer. No sales have been reported in the past three months.
Proto Labs, Inc. Hits New 52-Week High of $75.48, Up 134.48%
Proto Labs, Inc. has reached a new 52-week high of $75.48, marking a 134.48% increase over the past year, significantly outperforming the S&P 500. The company, a small-cap player in the specialty chemicals industry with a market capitalization of $1,313 million, shows resilience despite a five-year decline in operating profit. This strong performance is backed by impressive financial metrics including a high inventory turnover ratio and peak net sales for the latest quarter.
PRLB - Proto Labs Inc Stock Price and Quote
This article provides a comprehensive overview of Proto Labs Inc (PRLB) stock, including its current price, key financial metrics, performance indicators, and recent news. It details analyst ratings, insider transactions, and a list of executive leadership, offering a detailed snapshot for potential investors.
Proto Labs (PRLB) CEO uses 1,247 shares to cover tax obligation
Proto Labs Inc. President and CEO Krishna Suresh completed a tax-related share disposition on May 23, 2026, using 1,247 shares of common stock at $71.36 per share to cover a tax obligation. This non-market transaction resulted in Suresh directly holding 30,147 shares of Proto Labs common stock afterward. This type of transaction is a common method for insiders to pay tax liabilities with shares rather than cash and is considered neutral in its market impact.
Proto Labs stock reaches 52-week high at 73.36 USD By Investing.com
Proto Labs Inc. (PRLB) stock has hit a 52-week high of $73.26 USD, reflecting a nearly 94% total return over the past year and a 40% gain in the last six months. The company boasts a Piotroski Score of 9, indicating strong financial health, and recently surpassed Q1 2026 earnings and revenue expectations. Shareholders also approved director nominees and an amendment to the Long-Term Incentive Plan.
Proto Labs stock reaches 52-week high at 73.36 USD
Proto Labs Inc. (PRLB) stock has hit a new 52-week high of $73.26, reflecting a significant 94% total return over the past year and a 40% gain in the last six months. This strong performance, supported by a perfect Piotroski Score of 9, indicates robust financial health and investor confidence. The achievement follows better-than-expected Q1 2026 earnings and various positive strategic and operational developments.
Proto Labs stock reaches 52-week high at 73.36 USD
Proto Labs Inc. (PRLB) stock has reached a new 52-week high of $73.26, reflecting a nearly 94% return over the past year, including a 40% gain in the last six months. This milestone follows robust first-quarter earnings, where the company surpassed analyst expectations and reported a record revenue of $139.3 million. Despite its strong financial health and market position, InvestingPro indicates the stock is currently trading above its Fair Value.
PRLB Technical Analysis & Stock Price Forecast
This article provides a technical analysis and stock price forecast for Proto Labs Inc (PRLB), indicating a "Strong Buy" consensus based on various technical indicators and moving averages. Key metrics like MACD and moving averages suggest a bullish outlook, while RSI shows a neutral condition. The article also outlines support and resistance levels for the stock.
[Form 4] Proto Labs Inc Insider Trading Activity
Proto Labs Inc.'s Chief Financial Officer, Daniel Schumacher, reported a tax-related share disposition. On May 20, 2026, 255 shares of common stock were withheld at $71.13 per share to cover tax obligations, leaving him with 45,019 directly held shares. This transaction is classified as a tax-withholding disposition and not an open-market sale.
Proto Labs (PRLB) Chief Commercial Officer files initial Form 3 ownership report
Proto Labs Inc. (PRLB) has filed an initial Form 3 for Bernardo Parlange, its Chief Commercial Officer, establishing his beneficial ownership position. This filing is a baseline statement and reports no stock transactions or changes in holdings, indicating a neutral impact on the stock. The document serves to officially acknowledge his insider status rather than reflect any buying or selling activity.
Proto Labs (PRLB) CCO receives new RSU and stock option awards
Proto Labs Inc.'s Chief Commercial Officer, Bernardo Parlange, was granted 2,109 restricted stock units (RSUs) and options for 3,789 shares of common stock with an exercise price of $71.13 per share. Both the RSUs and stock options will vest in four equal annual installments, beginning on May 20, 2027. This equity compensation aims to align his interests with the company's long-term performance.
Proto Labs Shareholders Approve Directors, Auditor and Compensation
Proto Labs shareholders have approved all board-nominated directors, ratified Ernst & Young LLP as the independent auditor, and endorsed the executive compensation program. They also opted for annual say-on-pay votes and approved an amendment to the 2022 Long-Term Incentive Plan, reinforcing confidence in the company's governance and incentive structures. Analysts currently rate Proto Labs (PRLB) as a "Buy" with a $75.00 price target, and TipRanks' AI Analyst, Spark, rates it as "Outperform" due to its financial strength and operating momentum.
Proto Labs, Inc. (PRLB) hits fresh high: Is there still room to run?
Proto Labs, Inc. (PRLB) recently reached a new 52-week high, indicating strong investor confidence and positive market sentiment. The article's primary focus is to analyze whether this upward trend is sustainable and if the stock still presents a viable investment opportunity for future growth, given its current valuation and market performance.
Q1 2026 Proto Labs Inc Earnings Call Transcript
Proto Labs Inc (PRLB) reported record Q1 2026 revenue of $139.3 million, a 10.4% year-over-year increase, and achieved its highest non-GAAP EPS in over five years, driven by strong CNC machining demand and U.S. market growth. Despite these positive results, European revenue declined, 3D printing revenue was flat, and macroeconomic uncertainties led to conservative full-year guidance. The company also announced achieving AS9100 certification in Europe and ongoing operational changes.
[Form 4] Proto Labs Inc Insider Trading Activity
Proto Labs Inc. director Sujeet Chand reported an acquisition of 2,210 shares of common stock as deferred stock units with no cash price. These units vest on the earlier of the first anniversary of the grant date or the 2027 Annual Meeting of Shareholders and must be held until Chand's service on the Board ends. Following this transaction, Chand directly holds 26,863 shares of Proto Labs common stock.
Proto Labs (PRLB) director granted 2,210 deferred stock units
Proto Labs Inc. director Moonhie Chin was granted 2,210 deferred stock units on May 19, 2026, at a price of $0.0000 per share, increasing her direct holdings to 22,306 shares. These units vest fully on the earlier of the first anniversary of the grant date or the company's 2027 Annual Meeting of Shareholders, and must be held until her service on the Board of Directors ends. This transaction was reported in a Form 4 filing and is considered a neutral event for the stock.
Proto Labs (PRLB) director receives 2,210 restricted stock units as equity grant
Proto Labs director Donald G. Krantz was granted 2,210 restricted stock units (RSUs) as an equity award, not a market purchase. These RSUs, valued at $0.00 per share, will vest fully on the earlier of one year from the grant date or the 2027 Annual Meeting of Shareholders. Following this transaction, Krantz directly holds 26,863 shares of Proto Labs common stock.
Proto Labs (PRLB) holders back pay, auditor and 2022 incentive plan changes
Proto Labs shareholders recently approved several key proposals at their Annual Meeting, including an amendment to the 2022 Long-Term Incentive Plan to add 395,000 shares for equity awards. They also elected all seven board nominees, ratified Ernst & Young LLP as their independent public accounting firm for fiscal year 2026, and expressed advisory support for executive compensation. Shareholders further opted for annual advisory votes on executive pay.
Proto Labs Shareholders Approve Directors, Auditor and Compensation
Proto Labs (PRLB) shareholders re-elected all seven director nominees, ratified Ernst & Young as the 2026 independent auditor, and approved executive compensation in an advisory vote. Investors also opted for annual say-on-pay votes and cleared an amendment to the 2022 Long-Term Incentive Plan, reinforcing stability in governance and compensation practices. TipRanks' AI Analyst, Spark, rated PRLB as "Outperform," citing strong financial health and cash generation despite high P/E valuation and market uncertainties in Europe.
Proto Labs shareholders approve director slate and incentive plan amendment
Proto Labs Inc. shareholders approved the election of all seven director nominees and an amendment to the 2022 Long-Term Incentive Plan, increasing available shares by 395,000. The company, which has seen its shares return 72% over the past year, also ratified Ernst & Young LLP as its accounting firm and approved executive compensation. These approvals follow strong financial results, including first-quarter 2026 earnings that surpassed analyst expectations.
Proto Labs shareholders approve director slate and incentive plan amendment
Proto Labs (NYSE: PRLB) shareholders have approved all seven director nominees to serve until the next annual meeting and an amendment to the 2022 Long-Term Incentive Plan, increasing shares available for issuance by 395,000. These decisions were made during the company's Annual Meeting, following strong financial performance including a 72% return over the past year and a perfect Piotroski Score of 9.
Proto Labs Inc Annual Shareholders Meeting Transcript
This article provides the transcript of the Proto Labs Inc Annual Shareholders Meeting held on May 19, 2026, at 01:30 PM GMT. The meeting was called to order by Suresh Krishna, President, Chief Executive Officer, and Director of ProtoLabs, who welcomed attendees and introduced the company's directors. The content also lists various past earnings call transcripts and conference appearances for Proto Labs Inc.
Precision Trading with Proto Labs Inc. (PRLB) Risk Zones
This article from Stock Traders Daily provides a detailed analysis of Proto Labs Inc. (PRLB), indicating strong sentiment across all time horizons but also elevated downside risk. It outlines distinct trading strategies (Position, Momentum Breakout, Risk Hedging) with specific entry, target, and stop-loss zones based on AI-generated signals. The analysis also includes multi-timeframe support and resistance levels for precision trading.
PRLB files Form 144: 7,433 shares to be sold after option exercise (PRLB)
Proto Labs Inc. (PRLB) has filed a Form 144 indicating a planned sale of 7,433 shares on May 11, 2026, stemming from an option exercise. The filing also details prior 10b5-1 sales by Michael Kenison, including 200 shares for $14,000 on May 7, 2026, and 5,000 shares for $332,315 on February 17, 2026. This notice provides transparency regarding insider trading plans and stock option exercises.
Proto Labs COO Michael Kenison sells $1.6m in company stock
Proto Labs COO Michael Kenison sold company stock worth $1.6 million on May 11 and 12, 2026, through a pre-arranged 10b5-1 trading plan. The sales occurred as Proto Labs shares traded near their 52-week high, having gained 72% over the past year and appearing overvalued according to InvestingPro analysis. Concurrently, Kenison acquired 14,960 shares by exercising employee stock options, bringing his direct holdings to 18,683 shares.
